BIOCON
Back to All Ratios
|
BIOCON Last 5 Year EV/CE History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EV/CE(x) | 0.78 | 2.16 | 2.82 | 2.42 | 3.20 |
What is the latest EV/CE ratio of BIOCON ?
Year | EV/CE |
---|---|
Mar2023 | 0.78 |
Mar2022 | 2.16 |
Mar2021 | 2.82 |
Mar2020 | 2.42 |
Mar2019 | 3.20 |
How is EV/CE of BIOCON Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2023 | 0.78 | -63.89 | |
Mar2022 | 2.16 | -23.40 | |
Mar2021 | 2.82 | 16.53 | |
Mar2020 | 2.42 | -24.38 | |
Mar2019 | 3.2 | - |
Other Financial Ratios of BIOCON
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of BIOCON
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BIOCON | ₹36,234.1 Cr | -1.4% | 11.7% | 27.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,026.0 Cr | 0.5% | -5.7% | 55.1% | Stock Analytics | |
CIPLA | ₹114,925.0 Cr | 1.1% | -4.4% | 55.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -0.7% | 9.4% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 0.1% | 1.1% | 28.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,736.0 Cr | 6% | 2.8% | 93.1% | Stock Analytics |
BIOCON Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BIOCON | -1.4% |
11.7% |
27.8% |
SENSEX | 0.2% |
-0.2% |
20.9% |
You may also like the below Video Courses